A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Sunovion Pharmaceuticals, Inc
Start Date
March 1, 2015
End Date
February 28, 2017
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Sunovion Pharmaceuticals, Inc
Start Date
March 1, 2015
End Date
February 28, 2017